Target-based hemostatic nanocomposite for fatal traumatic hemorrhages in military and civilian areas.

Backed by Amy Collette and WEEMING
Days Left
  • $6
  • 1%
  • 10
    days left

About This Project

Uncontrollable severe and heavy bleeding that poses a fatal risk is a worldwide problem. Because bleeding is the leading cause of preventable death in war traumas and a secondary cause of death in civilian traumas. Incompressible bleeding, particularly from the splanchnic and joint areas, remains the leading cause of preventable death in the military and civilian field.This hemostatic nanocomposite project is planned to reduce mortality in uncontrollable severe and heavy bleeding.

Ask the Scientists

Join The Discussion

What is the context of this research?

Hemorrhage is the leading cause of preventable death in combat trauma and the secondary cause of death in civilian trauma. A significant number of deaths due to hemorrhage occur before and in the first hour after hospital arrival [1].Hemorrhage, in particular noncompressible hemorrhage from the splanchnic (internal organs) and junctional regions , remains the leading cause of preventable death on the battlefield[2,3].

Therefore, hemostatic agents for prehospital and early in-hospital administration are particularly important [4,5].No current hemostatic agents meet all the requirements.Given the safety concerns with some currently used hemostatic materials,more efficient and safer hemostatic agents are still needed[6,7,8].Finally, nanotechnology has been applied for hemostasis[9,10,11].

What is the significance of this project?

The worldwide impact of bleeding from traumatic injuries on human health cannot be ignored. 12 percent of the global burden of disease is due to violence or accidental injuries. Hemorrhage is responsible for 30-40% of trauma deaths, and 33-56% of these deaths occur in the prehospital period [1]. Early intervention is important in traumatic bleeding. Efforts are underway to develop new hemostatic agents with a variety of delivery mechanisms to treat severe bleeding in a military and civilian setting. Hemostatic agents are needed to provide hemostasis effectively and safely in emergency scenarios in both civil and military traumatic environments. Target-based hemostatic nanocomposite, which will be created by utilizing the possibilities of nanotechnology, is capable of meeting current needs.

What are the goals of the project?

Our first goal in this project is to obtain nanomaterials to be used in the production of hemostatic nanocomposites by green synthesis method. The biocompatibility and toxicity of the obtained nanomaterials will be evaluated under different conditions. As a result of examination and evaluation, nanocomposites will be formed by combining nanomaterials. Whether the obtained nanocomposites provide hemostasis safely and effectively will be tested in blood pools in experimental containers. This testing phase will be carried out taking into account different factors. Because it is aimed that the nanocomposite to be used as a hemostatic agent can meet the current needs.


Please wait...

Space will be rented in nano study laboratories for hemostatic nanocomposite. General consumables and chemicals will be purchased for nanomaterial synthesis. 10 protein purification kits will be used to quickly obtain the proteins. An automatic pipette will be purchased for general laboratory use. I can complete my project with the fund created.

Endorsed by

This project is a project that focuses on reducing the mortality rate in the community in fatal heavy and severe hemorrhages and deals with current approaches. Making hemostatic nanocomposites using the possibilities of nanotechnology can fill the gap in the need for hemostatic agents that will meet all requirements. The effective and correct conclusion of the project can improve the quality of life of humanity.

Flag iconProject Timeline

I started my hemostatic nanocomposite project. I plan to complete the project on time by following the timeline. After I finish my project, I will share the data of my results in an article.

Dec 26, 2021

Project starts

Jan 13, 2022

Project Launched

Feb 03, 2022

Purchase of consumables and other consumables

Feb 21, 2022

Synthesis of nanomaterials by green synthesis method

May 27, 2022

Study of nanomaterials

Meet the Team

İsa Kemal Asya
İsa Kemal Asya

İsa Kemal Asya

I am a bionanotechnologist and am working on highly biocompatible nanocomposites for use in tissue regeneration in the field of medical bionanotechnology.

Lab Notes

Nothing posted yet.

Project Backers

  • 2Backers
  • 1%Funded
  • $6Total Donations
  • $3.00Average Donation
Please wait...

See Your Scientific Impact

You can help a unique discovery by joining 2 other backers.
Fund This Project
Project journal